Literature DB >> 26234422

Differential effects of central administration of relaxin-3 on food intake and hypothalamic neuropeptides in male and female rats.

J Calvez1, C Lenglos1, C de Ávila1, G Guèvremont1, E Timofeeva1.   

Abstract

Relaxin-3 (RLN3) is an orexigenic neuropeptide that produces sex-specific effects on food intake by stronger stimulation of feeding in female compared with male rats. This study determined which hypothalamic nuclei and associated neuropeptides may be involved in the sex-specific orexigenic effects of RLN3. Relaxin-3 (800 pmol) or vehicle was injected into the lateral ventricle of female and male rats. Food and water intake were measured after the first injection, and rats were euthanized after the second injection to determine the mRNA expression of the hypothalamic neuropeptides. Food but not water intake showed sex-specific effects of RLN3. Stimulation of food intake by RLN3 was significantly higher in female than in male rats. No effect of RLN3 injection was found on c-fos mRNA expression in the arcuate, dorsomedial and ventromedial hypothalamic nuclei. Increased c-fos mRNA expression was observed in the paraventricular hypothalamic nucleus (PVN) in both sexes and in the lateral hypothalamic area (LHA) in female rats. Relaxin-3 injections led to a sex-nonspecific increase in the expression of oxytocin mRNA in the magnocellular PVN. Conversely, RLN3-induced expression of anorexigenic neuropeptide arginine vasopressin (AVP) was significantly higher in the parvocellular PVN in male compared with female rats. Finally, RLN3 administration significantly increased the expression of orexin (ORX) mRNA in the LHA in female but not in male rats. Stronger expression of anorexigenic AVP in the PVN in male rats and increased expression of ORX in the LHA in female rats may contribute to stronger orexigenic effects of RLN3 in female rats compared with male rats.
© 2015 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  c-Fos; food intake; orexin; oxytocin; relaxin-3; sex-specific; vasopressin

Mesh:

Substances:

Year:  2015        PMID: 26234422     DOI: 10.1111/gbb.12236

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  9 in total

1.  Relaxin-3/RXFP3 signalling in mouse hypothalamus: no effect of RXFP3 activation on corticosterone, despite reduced presynaptic excitatory input onto paraventricular CRH neurons in vitro.

Authors:  C Zhang; D V Baimoukhametova; C M Smith; J S Bains; Andrew L Gundlach
Journal:  Psychopharmacology (Berl)       Date:  2017-03-17       Impact factor: 4.530

Review 2.  Sex-specific effects of relaxin-3 on food intake and body weight gain.

Authors:  Juliane Calvez; Camila de Ávila; Elena Timofeeva
Journal:  Br J Pharmacol       Date:  2016-07-13       Impact factor: 8.739

3.  Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3-RXFP3 signalling.

Authors:  Alan Kania; Anna Gugula; Agnieszka Grabowiecka; Camila de Ávila; Tomasz Blasiak; Zenon Rajfur; Marian H Lewandowski; Grzegorz Hess; Elena Timofeeva; Andrew L Gundlach; Anna Blasiak
Journal:  J Physiol       Date:  2017-02-27       Impact factor: 5.182

4.  Stress and Sucrose Intake Modulate Neuronal Activity in the Anterior Hypothalamic Area in Rats.

Authors:  Arojit Mitra; Geneviève Guèvremont; Elena Timofeeva
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

Review 5.  Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders.

Authors:  Jigna Rajesh Kumar; Ramamoorthy Rajkumar; Tharindunee Jayakody; Subhi Marwari; Jia Mei Hong; Sherie Ma; Andrew L Gundlach; Mitchell K P Lai; Gavin S Dawe
Journal:  Br J Pharmacol       Date:  2016-09-06       Impact factor: 8.739

Review 6.  Interactions of Circadian Rhythmicity, Stress and Orexigenic Neuropeptide Systems: Implications for Food Intake Control.

Authors:  Anna Blasiak; Andrew L Gundlach; Grzegorz Hess; Marian H Lewandowski
Journal:  Front Neurosci       Date:  2017-03-20       Impact factor: 4.677

7.  Intranasal administration of a stapled relaxin-3 mimetic has anxiolytic- and antidepressant-like activity in rats.

Authors:  Subhi Marwari; Anders Poulsen; Norrapat Shih; Rajamani Lakshminarayanan; R Manjunatha Kini; Charles William Johannes; Brian William Dymock; Gavin Stewart Dawe
Journal:  Br J Pharmacol       Date:  2019-09-11       Impact factor: 8.739

8.  Effects of chronic silencing of relaxin-3 production in nucleus incertus neurons on food intake, body weight, anxiety-like behaviour and limbic brain activity in female rats.

Authors:  Camila de Ávila; Sandrine Chometton; Sherie Ma; Lola Torz Pedersen; Elena Timofeeva; Carlo Cifani; Andrew L Gundlach
Journal:  Psychopharmacology (Berl)       Date:  2020-01-03       Impact factor: 4.530

9.  RLN3/RXFP3 Signaling in the PVN Inhibits Magnocellular Neurons via M-like Current Activation and Contributes to Binge Eating Behavior.

Authors:  Alan Kania; Agata Szlaga; Patryk Sambak; Anna Gugula; Ewa Blasiak; Maria Vittoria Micioni Di Bonaventura; Mohammad Akhter Hossain; Carlo Cifani; Grzegorz Hess; Andrew L Gundlach; Anna Blasiak
Journal:  J Neurosci       Date:  2020-06-12       Impact factor: 6.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.